December 13, 2022 December 13, 2022Categories News StoriesImmunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL
December 13, 2022 December 13, 2022Categories News StoriesBlinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)
December 13, 2022 December 13, 2022Categories Press ReleasesPress Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)
December 11, 2022 December 11, 2022Categories Press ReleasesPress Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressive—yet highly curable—acute promyelocytic leukemia (APL)
December 6, 2022 December 6, 2022Categories Press ReleasesPress Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
October 28, 2022 October 28, 2022Categories Press ReleasesPress Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting
March 25, 2022 March 25, 2022Categories Press ReleasesPress Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success
March 16, 2022 March 16, 2022Categories Press ReleasesPress Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations
